Medtronic plc Quarterly Additional Paid in Capital in USD from Q4 2014 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.
Summary
Medtronic plc quarterly Additional Paid in Capital history and growth rate from Q4 2014 to Q2 2024.
  • Medtronic plc Additional Paid in Capital for the quarter ending July 26, 2024 was $20.8B, a 15.4% decline year-over-year.
Additional Paid in Capital, Quarterly (USD)
Additional Paid in Capital, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $20.8B -$3.78B -15.4% Jul 26, 2024 10-Q 2024-08-27
Q1 2024 $23.1B -$1.46B -5.94% Apr 26, 2024 10-Q 2024-08-27
Q4 2023 $24.6B +$76M +0.31% Jan 26, 2024 10-Q 2024-02-27
Q3 2023 $24.6B +$138M +0.57% Oct 27, 2023 10-Q 2023-11-30
Q2 2023 $24.6B +$252M +1.04% Jul 28, 2023 10-Q 2023-08-31
Q1 2023 $24.6B +$24M +0.1% Apr 28, 2023 10-K 2024-06-20
Q4 2022 $24.5B -$1.3B -5.04% Jan 27, 2023 10-Q 2023-03-01
Q3 2022 $24.4B -$1.62B -6.21% Oct 28, 2022 10-Q 2022-12-01
Q2 2022 $24.3B -$1.85B -7.06% Jul 29, 2022 10-Q 2022-09-01
Q1 2022 $24.6B -$1.75B -6.66% Apr 29, 2022 10-K 2023-06-22
Q4 2021 $25.8B -$851M -3.19% Jan 28, 2022 10-Q 2022-03-03
Q3 2021 $26.1B -$422M -1.59% Oct 29, 2021 10-Q 2021-12-02
Q2 2021 $26.2B -$77M -0.29% Jul 30, 2021 10-Q 2021-09-02
Q1 2021 $26.3B +$154M +0.59% Apr 30, 2021 10-K 2022-06-23
Q4 2020 $26.7B +$521M +1.99% Jan 29, 2021 10-Q 2021-03-05
Q3 2020 $26.5B +$310M +1.19% Oct 30, 2020 10-Q 2020-12-03
Q2 2020 $26.3B -$209M -0.79% Jul 31, 2020 10-Q 2020-09-03
Q1 2020 $26.2B -$367M -1.38% Apr 24, 2020 10-K 2021-06-25
Q4 2019 $26.1B -$374M -1.41% Jan 24, 2020 10-Q 2020-02-28
Q3 2019 $26.2B -$877M -3.24% Oct 25, 2019 10-Q 2019-12-03
Q2 2019 $26.5B -$1.35B -4.84% Jul 26, 2019 10-Q 2019-08-30
Q1 2019 $26.5B -$1.6B -5.67% Apr 26, 2019 10-K 2020-06-19
Q4 2018 $26.5B -$1.67B -5.93% Jan 25, 2019 10-Q 2019-03-01
Q3 2018 $27B -$1.04B -3.71% Oct 26, 2018 10-Q 2018-11-29
Q2 2018 $27.8B -$736M -2.58% Jul 27, 2018 10-Q 2018-08-31
Q1 2018 $28.1B -$1.42B -4.82% Apr 27, 2018 10-K 2019-06-21
Q4 2017 $28.2B Jan 26, 2018 10-Q 2018-03-02
Q3 2017 $28.1B Oct 27, 2017 10-Q 2017-12-04
Q2 2017 $28.6B Jul 28, 2017 10-Q 2017-09-01
Q1 2017 $29.6B -$2.68B -8.3% Apr 28, 2017 10-K 2018-06-22
Q1 2016 $32.2B Apr 29, 2016 10-K 2017-06-27
Q4 2014 $73K* Jan 23, 2015 10-Q 2015-02-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.